Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2022	12-2021	12-2020	12-2019	12-2018
Assets
Current Assets
Cash & Cash Equivalents	235,260	413,083	885,562	46,535	32,694
Marketable Securities	848,577	1,078,257	504,544	368,515	190,096
Receivables	865	N/A	N/A	N/A	N/A
Inventories	3,020	N/A	N/A	N/A	N/A
Other current assets	21,239	16,643	13,537	9,357	3,870
TOTAL	$1,108,961	$1,507,983	$1,403,643	$424,407	$226,660

Non-Current Assets
PPE Net	17,540	15,824	7,809	1,776	473
Investments And Advances	3,465	8,218	15,629	0	0
Intangibles	14,914	0	0	0	0
Other Non-Current Assets	57,767	56,729	49,047	6,017	1,321
TOTAL	$93,686	$80,771	$72,485	$7,793	$1,794

Total Assets	$1,202,647	$1,588,754	$1,476,128	$432,200	$228,454

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	38,861	35,163	18,117	48,082	25,775
Accrued Expenses	120,587	108,495	53,355	N/A	N/A
TOTAL	$159,448	$143,658	$71,472	$48,906	$26,146

Non-Current Liabilities
Deferred Revenues	N/A	N/A	N/A	824	371
aiOther Non-Current Liabilities	46,683	48,058	43,867	999	0
TOTAL	$46,683	$48,058	$43,867	$999	$732

Total Liabilities	$206,131	$191,716	$115,339	$49,905	$26,878

Shareholders' Equity
Shares Outstanding, K	58,038	55,488	50,634	43,480	35,268
Common Shares	58	55	50	40	33
Retained earnings	-2,452,889	-1,712,022	-1,130,238	-772,301	-559,045
Other shareholders' equity	-3,719	9,068	9,759	9,889	9,479
TOTAL	$996,516	$1,397,038	$1,360,789	$382,295	$201,576

Total Liabilities And Equity	$1,202,647	$1,588,754	$1,476,128	$432,200	$228,454